financetom
Business
financetom
/
Business
/
Redwire Awarded NASA Contract to Conduct Mars Surface-Imaging Study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Redwire Awarded NASA Contract to Conduct Mars Surface-Imaging Study
May 21, 2024 9:33 AM

12:26 PM EDT, 05/21/2024 (MT Newswires) -- Redwire ( RDW ) said Tuesday that it has been awarded a NASA contract to conduct a study to conceptualize a commercial Mars spacecraft that will provide Mars surface imagery to industry and government customers.

The concept, based on Redwire's ( RDW ) spacecraft technology, could be used to support future Mars exploration missions, the company said.

Terms of the contract were not disclosed.

Redwire ( RDW ) shares were nearly 1% higher in recent trading.

Price: 5.02, Change: +0.06, Percent Change: +1.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Else Nutrition Q1 Net Loss Narrows
Else Nutrition Q1 Net Loss Narrows
Aug 21, 2025
09:20 AM EDT, 08/21/2025 (MT Newswires) -- Else Nutrition ( BABYF ) , a food and nutrition company, on Thursday reported a narrowed net loss in the first quarter. For the three-months ended March 31, net loss narrowed to $3.4 million or per basic and fully diluted share of $0.01, compared with $5.5 million or $0.04 per share, a year...
Nio Stock Is Moving Higher Thursday: What's Driving The Action?
Nio Stock Is Moving Higher Thursday: What's Driving The Action?
Aug 21, 2025
NIO Inc ( NIO ) shares are trading higher Thursday after the company’s new ES8 SUV went on display in showrooms across China. What To Know: Nio is debuting its new ES8 SUV at a launch event in China on Thursday. In preparation for the event, the SUV has entered showrooms and is on display in more than 300 retail...
Update: Market Chatter: CVS Health Won't Cover Gilead's New HIV Prevention Drug Yet
Update: Market Chatter: CVS Health Won't Cover Gilead's New HIV Prevention Drug Yet
Aug 21, 2025
09:21 AM EDT, 08/21/2025 (MT Newswires) -- (Update to add Gilead's comment in the fourth paragraph) CVS Health ( CVS ) has decided not to include Gilead Sciences' (GILD) new HIV prevention drug, Yeztugo, in its commercial or Affordable Care Act plans for now, Reuters reported Thursday, citing company spokesperson David Whitrap. The company cited clinical, financial and regulatory reasons,...
US probing delays in Tesla crash reports involving driver assistance systems
US probing delays in Tesla crash reports involving driver assistance systems
Aug 21, 2025
(Reuters) -The National Highway Traffic Safety Administration said Thursday it is opening an investigation into delays in Tesla reports of crashes involving advanced driver assistance systems or self-driving vehicles. The auto safety agency said it has identified numerous incident reports submitted by Tesla in which reported crashes occurred several months or more before the dates of the reports, while the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved